Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemostasis using PuraStat for gastrointestinal bleeding in malignant tumors
jRCTs042230057Active, not recruiting
- Sponsor
- 3-D Matrix
- Start
- Aug 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of PuraStat in gastrointestinal bleeding and gastrointestinal cancer, sponsored by 3-D Matrix. Primary endpoint: Rate of successful hemostasis of bleeding from malignant tumors. Started Aug 2023; status: active, not recruiting.
02
Drugs
PuraStat
03
Conditions
gastrointestinal bleedinggastrointestinal cancer
Beyond the preview
Go deeper on jRCTs042230057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042230057.